RecruitingNCT01238250
Rare condition
Autism spectrum disorder due to AUTS2 deficiency
1
studies recruiting now
as of 7 Sept 2026
1
studies registered in total
as of 7 Sept 2026
1
countries with a recruiting site
as of 7 Sept 2026
10 Nov 2010
most recent study posted
among recruiting studies
Recruiting trials
Showing the 1 most recently updated recruiting study, as recorded 7 Sept 2026. Live status on each study page.
Search all Autism spectrum disorder due to AUTS2 deficiency studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Autism spectrum disorder due to AUTS2 deficiency study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Autism spectrum disorder due to AUTS2 deficiency
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (AUTS2).
Treatments being studied
2 approved treatments and 54 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Oxytocin (Orasthin)Approved: Aripiprazole (Abilify)
Phase 3Arbaclofen
Phase 3Cariprazine (Reagila)
Phase 3Balovaptan
Phase 3Melatonin (Circadin)
Phase 3Mirtazapine (Mirtazapine)
Phase 3Memantine
Phase 3Risperidone (Okedi)
Phase 3Colistimethate Sodium (Colistimethate sodium)
+ 46 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).